[1] GU Y, CHEN D, ZHOU L, et al. Lysine-specific demethylase 1 inhibition enhances autophagy and attenuates early-stage post-spinal cord injury apoptosis. Cell Death Discov. 2021;7(1):69.
[2] ZHENG Y, MAO YR, YUAN TF, et al. Multimodal treatment for spinal cord injury: a sword of neuroregeneration upon neuromodulation. Neural Regen Res. 2020;15(8):1437-1450.
[3] LAI Z, LIU H, LIU G. Meta-Analysis on the Effects of Electric Acupuncture on Neural Functional Recovery and Related Pathways of Rats after Spinal Cord Injury. Biomed Res Int. 2022;2022:8613384.
[4] KYRITSIS N, TORRES-ESPÍN A, SCHUPP PG, et al. Diagnostic blood RNA profiles for human acute spinal cord injury. J Exp Med. 2021;218(3): e20201795.
[5] BYKOWSKI EA, PETERSSON JN, DUKELOW S, et al. Urinary biomarkers indicative of recovery from spinal cord injury: A pilot study. IBRO Neurosci Rep. 2021;10:178-185.
[6] 杨新乐,王明,杨成伟,等.脊髓损伤的代谢组学研究进展[J].中国康复理论与实践,2018,24(8):904-908.
[7] WANG X, ZHANG L, SUN W, et al. Changes of Metabolites in Acute Ischemic Stroke and Its Subtypes. Front Neurosci. 2021;14:580929.
[8] BANOEI MM, CASAULT C, METWALY SM, et al. Metabolomics and Biomarker Discovery in Traumatic Brain Injury. J Neurotrauma. 2018;35(16):1831-1848.
[9] ZHOU Y, ZHANG X, CHEN R, et al. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis. Clin Rheumatol. 2020;39(8):2325-2336.
[10] 梁子超,李智炜,赖铿,等.10折交叉验证用于预测模型泛化能力评价及其R软件实现[J].中国医院统计,2020,27(4):289-292.
[11] RUPP R, BIERING-SØRENSEN F, BURNS SP, et al. International Standards for Neurological Classification of Spinal Cord Injury: Revised 2019. Top Spinal Cord Inj Rehabil. 2021;27(2):1-22.
[12] 康海琼,周红俊,刘根林,等.脊髓损伤神经学分类国际标准检查表2019版最新修订及解读[J].中国康复理论与实践,2019,25(8):983-985.
[13] WANG R, LIU S, LIU T, et al. Mass spectrometry-based serum lipidomics strategy to explore the mechanism of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves in the treatment of ischemic stroke. Food Funct. 2021;12(10):4519-4534.
[14] KWON BK, STREIJGER F, FALLAH N, et al. Cerebrospinal Fluid Biomarkers To Stratify Injury Severity and Predict Outcome in Human Traumatic Spinal Cord Injury. J Neurotrauma. 2017;34(3):567-580.
[15] FAN B, WEI Z, FENG S. Progression in translational research on spinal cord injury based on microenvironment imbalance. Bone Res. 2022;10(1):35.
[16] PANG Y, LIU X, ZHAO C, et al. LC-MS/MS-based arachidonic acid metabolomics in acute spinal cord injury reveals the upregulation of 5-LOX and COX-2 products. Free Radic Biol Med. 2022;193(Pt 1):363-372.
[17] 胡华辉,黄小龙,全仁夫,等.急性脊髓损伤模型大鼠血清和脊髓的代谢组学研究[J].中国骨伤,2017,30(2):152-158.
[18] LIU Z, KUMAR M, KABRA A. Cucurbitacin B exerts neuroprotection in a murine Alzheimer’s disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. Front Biosci (Landmark Ed). 2022;27(2):71.
[19] JI L, CHEN S, GU G, et al. Discovery of potential biomarkers for human atherosclerotic abdominal aortic aneurysm through untargeted metabolomics and transcriptomics. J Zhejiang Univ Sci B. 2021;22(9):733-745.
[20] DOLCI S, MANNINO L, BOTTANI E, et al. Therapeutic induction of energy metabolism reduces neural tissue damage and increases microglia activation in severe spinal cord injury. Pharmacol Res. 2022;178:106149.
[21] WANG R, SHI L, LIU S, et al. Mass spectrometry-based urinary metabolomics for the investigation on the mechanism of action of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves against ischemic stroke in rats. J Ethnopharmacol. 2019;241:111969.
[22] FUJIEDA Y, UENO S, OGINO R, et al. Metabolite profiles correlate closely with neurobehavioral function in experimental spinal cord injury in rats. PLoS One. 2012;7(8):e43152.
[23] PENG J, ZENG J, CAI B, et al. Establishment of quantitative severity evaluation model for spinal cord injury by metabolomic fingerprinting. PLoS One. 2014;9(4):e93736.
[24] JONES ZB, REN Y. Sphingolipids in spinal cord injury. Int J Physiol Pathophysiol Pharmacol. 2016;8(2):52-69.
[25] DALKILIC T, FALLAH N, NOONAN VK, et al. Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers. J Neurotrauma. 2018;35(3):435-445.
[26] HUFFMAN EE, DONG BE, CLARKE HA, et al. Cervical spinal cord injury leads to injury and altered metabolism in the lungs. Brain Commun. 2023; 5(2):fcad091.
[27] MAR FM, DA SILVA TF, MORGADO MM, et al. Myelin Lipids Inhibit Axon Regeneration Following Spinal Cord Injury: a Novel Perspective for Therapy. Mol Neurobiol. 2016;53(2):1052-1064.
[28] PATWARDHAN AM, SCOTLAND PE, AKOPIAN AN, et al. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci U S A. 2009;106(44): 18820-18824.
[29] LIM SN, HUANG W, HALL JC, et al. Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp Neurol. 2013;239:13-27.
[30] TANG J, ZENG X, LI H, et al. Repulsive Guidance Molecule-a and Central Nervous System Diseases. Biomed Res Int. 2021;2021:5532116.
[31] MCFADDEN K, MINSHEW NJ. Evidence for dysregulation of axonal growth and guidance in the etiology of ASD. Front Hum Neurosci. 2013;7:671.
[32] FUJITA Y, YAMASHITA T. The roles of RGMa-neogenin signaling in inflammation and angiogenesis. Inflamm Regen. 2017;37:6.
[33] FREUND P, SEIF M, WEISKOPF N, et al. MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. Lancet Neurol. 2019;18(12):1123-1135.
[34] CHAY W, KIRSHBLUM S. Predicting Outcomes After Spinal Cord Injury. Phys Med Rehabil Clin N Am. 2020;31(3):331-343.
[35] MAILLARD MP, ROSSAT J, BRUNNER HR, et al. Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding. J Pharmacol Exp Ther. 2000;295(2):649-654.
[36] GROOTHUIS JT, THIJSSEN DH, RONGEN GA, et al. Angiotensin II contributes to the increased baseline leg vascular resistance in spinal cord-injured individuals. J Hypertens. 2010;28(10):2094-2101.
[37] JÄRVE A, TODIRAS M, LIAN X, et al. Distinct roles of angiotensin receptors in autonomic dysreflexia following high-level spinal cord injury in mice. Exp Neurol. 2019;311:173-181.
[38] ASSIS AD, MASCARENHAS FNADP, ARAÚJO FA, et al. Angiotensin-(1-7) receptor Mas antagonist (A779) influenced gliosis and reduced synaptic density in the spinal cord after peripheral axotomy. Peptides. 2020;129: 170329.
[39] KU JM, KIM SR, HONG SH, et al. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Mol Cell Biochem. 2015;409 (1-2):33-43.
[40] MUTALIK SP, GUPTON SL. Glycosylation in Axonal Guidance. Int J Mol Sci. 2021;22(10):5143.
[41] SOLEILHAVOUP C, TRAVAGLIO M, PATRICK K, et al. Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. Nat Commun. 2020;11(1):3111.
[42] Í DALI C, GROESCHEL S, MOLDOVAN M, et al. Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study. Ann Clin Transl Neurol. 2021;8(1):66-80.
[43] CRUZ CD, COELHO A, ANTUNES-LOPES T, et al. Biomarkers of spinal cord injury and ensuing bladder dysfunction. Adv Drug Deliv Rev. 2015;82-83: 153-159.
[44] YANG H, ZHANG P, XIE M, et al. Parallel Metabolomic Profiling of Cerebrospinal Fluid, Plasma, and Spinal Cord to Identify Biomarkers for Spinal Cord Injury. J Mol Neurosci. 2022;72(1):126-135. |